Trial Profile
A Phase II Study of Ofatumumab in Combination With High-dose Methylprednisolone in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2023
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Methylprednisolone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 14 Sep 2010 New source identified and integrated (Moores UCSD Cancer Center record 7012).
- 08 Sep 2010 New trial record